Literature DB >> 27272822

Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.

Shinji Itoh1, Tomoharu Yoshizumi2, Koichi Kimura2, Hirohisa Okabe2, Norifumi Harimoto2, Toru Ikegami2, Hideaki Uchiyama2, Ken Shirabe2, Akihiro Nishie3, Yoshihiko Maehara2.   

Abstract

BACKGROUND/AIM: We aimed to evaluate the effect of body composition on the outcome of living-donor liver transplantation (LDLT) in patients with hepatocellular carcinoma (HCC). PATIENTS AND METHODS: We performed LDLT in 153 patients with HCC and divided the patients into two groups based on skeletal muscle mass-to-visceral fat area ratio (SVR), as assessed by computed tomography (CT) measurement, namely a low-SVR group (n=38) and a not-low SVR group (n=112). We compared surgical outcomes between the two groups.
RESULTS: A low SVR was significantly correlated with a higher body mass index and male sex. No differences were found between the two groups in terms of other factors. The patients in the low-SVR group had a significantly poorer prognosis than those in the not-low SVR group in terms of recurrence-free (p=0.01) and overall (p=0.03) survival. The results of the multivariate analysis showed low SVR to be an independent and prognostic indicator for patients with HCC who had undergone LDLT.
CONCLUSION: Pre-transplant body composition measured by CT is a major determinant of prognosis in LDLT for HCC in Japan. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; body composition; living-donor liver transplantation; sarcopenic obesity

Mesh:

Year:  2016        PMID: 27272822

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

Review 1.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

2.  Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Takeo Toshima; Tomoharu Yoshizumi; Yukiko Kosai-Fujimoto; Shoichi Inokuchi; Shohei Yoshiya; Kazuki Takeishi; Shinji Itoh; Noboru Harada; Toru Ikegami; Yuji Soejima; Masaki Mori
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

3.  Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms.

Authors:  Chengyu Liao; Ge Li; Yannan Bai; Songqiang Zhou; Long Huang; Maolin Yan; Funan Qiu; Jiangzhi Chen; Yaodong Wang; Yifeng Tian; Shi Chen
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Takashi Nishimura; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Nutrients       Date:  2017-06-16       Impact factor: 5.717

5.  Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis.

Authors:  Xiaoming Zhang; Xiaohua Xie; Qingli Dou; Chenyun Liu; Wenwu Zhang; Yunzhi Yang; Renli Deng; Andy S K Cheng
Journal:  BMC Geriatr       Date:  2019-07-03       Impact factor: 3.921

6.  Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Authors:  Karolina Grąt; Ryszard Pacho; Michał Grąt; Marek Krawczyk; Krzysztof Zieniewicz; Olgierd Rowiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

7.  Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.

Authors:  Young Ri Kim; Sukhee Park; Sangbin Han; Joong Hyun Ahn; Seonwoo Kim; Dong Hyun Sinn; Woo Kyoung Jeong; Justin S Ko; Mi Sook Gwak; Gaab Soo Kim
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

8.  Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.

Authors:  Yueh-Wei Liu; Chien-Chang Lu; Ching-Di Chang; Ko-Chao Lee; Hong Hwa Chen; Wen Shuo Yeh; Wang-Hseng Hu; Kai-Lung Tsai; Cheng-Hsi Yeh; Sin-Yong Wee; Shin-Min Yin; Chih-Chi Wang; Chao-Hung Hung
Journal:  Sci Rep       Date:  2020-04-15       Impact factor: 4.379

Review 9.  Obesity in the Liver Transplant Setting.

Authors:  Carlos Moctezuma-Velazquez; Ernesto Márquez-Guillén; Aldo Torre
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

Review 10.  Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments.

Authors:  Giovanni Marasco; Matteo Serenari; Matteo Renzulli; Luigina Vanessa Alemanni; Benedetta Rossini; Irene Pettinari; Elton Dajti; Federico Ravaioli; Rita Golfieri; Matteo Cescon; Davide Festi; Antonio Colecchia
Journal:  J Gastroenterol       Date:  2020-08-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.